Conor McNamara
Stock Analyst at RBC Capital
(0.98)
# 3,841
Out of 4,984 analysts
137
Total ratings
26.73%
Success rate
-16.68%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $51.78 | +40.98% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $2.89 | +73.01% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $175.01 | +45.71% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.61 | +86.34% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $52.94 | -13.11% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $63.33 | +37.38% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $12.71 | +33.75% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $101.48 | +24.16% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $282.26 | +44.90% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $284.35 | +43.84% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $119.75 | +70.35% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $480.74 | +32.50% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $190.47 | +31.25% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $29.53 | +106.57% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.21 | +118.41% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $51.78
Upside: +40.98%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $2.89
Upside: +73.01%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $175.01
Upside: +45.71%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.61
Upside: +86.34%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $52.94
Upside: -13.11%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $63.33
Upside: +37.38%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $12.71
Upside: +33.75%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $101.48
Upside: +24.16%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $282.26
Upside: +44.90%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $284.35
Upside: +43.84%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $119.75
Upside: +70.35%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $480.74
Upside: +32.50%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $190.47
Upside: +31.25%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $29.53
Upside: +106.57%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.21
Upside: +118.41%